The Eph/ephrin system has been described as a tumor suppressor in duodenal cancer, while in esophageal, gastric, hepatic, and pancreatic cancer, the system has been related to tumor progression. The gene discussed is EPHA1; the disease is familial pancreatic carcinoma.